PE20011092A1 - COMPOSITIONS FOR THE TOPICAL DELIVERY OF A PHARMACEUTICALLY ACTIVE AGENT THAT HAS REDUCED SKIN IRRITATION - Google Patents

COMPOSITIONS FOR THE TOPICAL DELIVERY OF A PHARMACEUTICALLY ACTIVE AGENT THAT HAS REDUCED SKIN IRRITATION

Info

Publication number
PE20011092A1
PE20011092A1 PE2001000150A PE2001000150A PE20011092A1 PE 20011092 A1 PE20011092 A1 PE 20011092A1 PE 2001000150 A PE2001000150 A PE 2001000150A PE 2001000150 A PE2001000150 A PE 2001000150A PE 20011092 A1 PE20011092 A1 PE 20011092A1
Authority
PE
Peru
Prior art keywords
compositions
active agent
pharmaceutically active
skin irritation
topical delivery
Prior art date
Application number
PE2001000150A
Other languages
Spanish (es)
Inventor
Paul Robert Tanner
Thomas Edward Huetter
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE20011092A1 publication Critical patent/PE20011092A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Abstract

SE REFIERE A UNA COMPOSICION QUE COMPRENDE: a) DE 1% A 50% EN PESO DE POR LO MENOS UN FOSFOLIPIDO TAL COMO FOSFOLIPIDOS INSATURADOS, PARCIALMENTE SATURADOS O SUS MEZCLAS DE PREFERENCIA LECITINA, FOSFATIDILCOLINA, FOSFADILETANOAMINA, FOSFATIDILSERINA, ENTRE OTROS ; b) DE 0,1% A 50% EN PESO DE POR LO MENOS UN AGENTE ACONDICIONADOR DE LA PIEL TAL COMO PETROLATO, PARAFINALIQUIDA, CERA DE PARAFINA, CERA DE ABEJAS , ESPERMACETI, ALCOHOL CETILICO, ENTRE OTROS, DE PREFERENCIA GLICERINA, PETROLATO, LANOLINA; c) DE 0,01% A 10% DE POR LO MENOS UN AGENTE FARMACEUTICAMNERTE ACTIVO; d) UN PORTADOR. LA COMPOSICIONES ES UTIL PARA PREVENIR O REDUCIR LA SEQUEDAD, IRRITACION, PRURITO EN LA PIELIT REFERS TO A COMPOSITION THAT INCLUDES: a) FROM 1% TO 50% BY WEIGHT OF AT LEAST ONE PHOSPHOLIPID SUCH AS UNSATURATED PHOSPHOLIPIDS, PARTIALLY SATURATED OR THEIR PREFERRED MIXTURES LECITHIN, PHOSPHATIDYLCOLINE, PHOSPHEROSTRYLETHANEANE; b) FROM 0.1% TO 50% BY WEIGHT OF AT LEAST ONE SKIN CONDITIONING AGENT SUCH AS PETROLATE, PARAFFINALIQUID, PARAFFIN WAX, BEE WAX, SPERMACETI, CETILIC ALCOHOL, AMONG OTHERS, PREFERRED GLYCERIN, PETROLATE, LANOLIN; c) FROM 0.01% TO 10% OF AT LEAST ONE ACTIVE PHARMACEUTICAL AGENT; d) A CARRIER. THE COMPOSITION IS USEFUL TO PREVENT OR REDUCE DRYING, IRRITATION, ITCHING OF THE SKIN

PE2001000150A 2000-02-14 2001-02-12 COMPOSITIONS FOR THE TOPICAL DELIVERY OF A PHARMACEUTICALLY ACTIVE AGENT THAT HAS REDUCED SKIN IRRITATION PE20011092A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50316800A 2000-02-14 2000-02-14
US50356800A 2000-02-14 2000-02-14

Publications (1)

Publication Number Publication Date
PE20011092A1 true PE20011092A1 (en) 2001-11-12

Family

ID=27054407

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000150A PE20011092A1 (en) 2000-02-14 2001-02-12 COMPOSITIONS FOR THE TOPICAL DELIVERY OF A PHARMACEUTICALLY ACTIVE AGENT THAT HAS REDUCED SKIN IRRITATION

Country Status (4)

Country Link
AU (1) AU2001236996A1 (en)
CO (1) CO5261579A1 (en)
PE (1) PE20011092A1 (en)
WO (1) WO2001060336A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119173A1 (en) * 2000-12-22 2002-08-29 Lin Samuel Qcheng Cosmetic compositions for preventing skin irritation
GB0704846D0 (en) 2007-03-13 2007-04-18 Futura Medical Dev Ltd Topical pharmaceutical formulation
PL214538B1 (en) * 2009-05-28 2013-08-30 P P F Hasco Lek Spolka Akcyjna Liposome composition containing naproxen and a method for production of liposome composition containing naproxen
BR112015027436A8 (en) * 2013-05-03 2018-01-16 Lipidor Ab topical composition and vehicle for administration of pharmaceutically or cosmetically active ingredients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
DE4021084C1 (en) * 1990-07-03 1991-11-21 Hans Dr. 5024 Pulheim De Lautenschlaeger Fumarate topical compsn. contg. liposome(s) improving bio-availability - esp. for treating psoriasis, contain liposomal structure, alcohol, stabiliser and fumaric acid (deriv.) and are stable and non irritant
US5766628A (en) * 1992-02-24 1998-06-16 Merz + Co. Gmbh & Co. Bath and shower composition having vesicle-forming properties and method for the production and use thereof
ES2136105T3 (en) * 1992-08-04 1999-11-16 Rhone Poulenc Rorer Gmbh PHARMACEUTICAL AND / OR COSMETIC PREPARATION.
US5945409A (en) * 1995-03-10 1999-08-31 Wilson T. Crandall Topical moisturizing composition and method

Also Published As

Publication number Publication date
WO2001060336A1 (en) 2001-08-23
AU2001236996A1 (en) 2001-08-27
CO5261579A1 (en) 2003-03-31

Similar Documents

Publication Publication Date Title
ES2178430T3 (en) USE OF GELIFICABLE PHARMACEUTICAL COMPOSITIONS IN PARODONTOLOGY.
ES2174517T3 (en) COSMETIC COMPOSITIONS WITH DIBENCILIDEN SORBITOL AND FUNCTIONALIZED SILICONES.
ES2184310T3 (en) SELF-EMULSIONING FORMULATION FOR LIPOFIL ACID COMPOUNDS
BR0008590A (en) Polymeric delivery agent, composition, unit dosage form, method for administering a biologically active agent to an animal requiring the agent, method for preparing a composition; it's composed
ES2103506T3 (en) USE OF HYDROXYCARBOXYLIC ACIDS AND THEIR DERIVATIVES FOR THE PREPARATION OF TOPICAL DERMATOLOGICAL COMPOSITIONS FOR THE TREATMENT OF WRINKLES.
ES2058109T3 (en) A PROCEDURE FOR THE PREPARATION OF A TOPIC ANTIMICROBIAL PHARMACEUTICAL COMPOSITION.
ECSP941104A (en) DERIVATIVES OF 2,6 DIAMINOPURINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
CO4340618A1 (en) PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE
BRPI0417287A (en) oily foam for pharmaceutical and cosmetic use
AR009643A1 (en) ANTIMICROBIAL COMPOSITIONS FOR PERSONAL CARE
ES2146300T3 (en) USE OF ANTIHELMINTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS CAUSED BY ANOPLOCEPHALA PERFOLIATA IN EQUIDS.
BRPI0822162B8 (en) pharmaceutical composition for topical treatment of nail disease or nail bed
PE20110642A1 (en) TOPIC ANTIFUNGAL FORMULATIONS BASED ON TERBINAFINE AND TERBINAFINE-SIMILAR COMPOUNDS AND METHODS OF USE
AR046878A1 (en) ENDOPARASITICIDE AGENT FOR TOPICAL ADMINISTRATION
AR033688A1 (en) RECONSTITUABLE PARENTERAL COMPOSITION
AR055591A1 (en) A SKIN PROTECTIVE TOPIC COMPOSITION AND ITS USE
CO5160296A1 (en) NEW FORMS OF PRESENTATION FOR ACTIVE LABOR AGENTS IN THE MIDDLE ACID, ACTIVE AGENT UNIT AND PROCESS FOR THE PRODUCTION OF SUCH AGENT UNIT
ES2175671T3 (en) AGENT FOR SKIN CARE.
PE20011092A1 (en) COMPOSITIONS FOR THE TOPICAL DELIVERY OF A PHARMACEUTICALLY ACTIVE AGENT THAT HAS REDUCED SKIN IRRITATION
BR112015027436A8 (en) topical composition and vehicle for administration of pharmaceutically or cosmetically active ingredients
CL2004001843A1 (en) COMBINATION OF (A) AT LEAST A 2,5-DIHYDROBENCENOSULPHONIC DERIVATIVE, AS CALCIUM DOBEYLATE, ETHAMSYLATE AND PERSILATE, AND (B) AT LEAST A MODULATOR OF POTASSIUM CHANNELS, PHARMACEUTICAL COMPOSITION CONTAINING AND USE AS A MEDICATION IN PROFILA
HRP20030907B1 (en) Pharmaceutical composition based on macrolides for topical application in ophthalmology
ES2628707T3 (en) Enhanced Topical Composition
PE20050443A1 (en) TRANSDERMAL PHARMACEUTICAL FORMULATIONS
ES2129448T3 (en) USE OF 2- (2-NITRO-4-TRIFLUOROMETILBENZOIL) -1,3-CYCLLOHEXANODIONA IN THE TREATMENT OF THYROSINEMIA AND PHARMACEUTICAL COMPOSITIONS.

Legal Events

Date Code Title Description
FD Application declared void or lapsed